Pfizer Inc. (PFE)
27.98
-0.09
(-0.32%)
USD |
NYSE |
Aug 24, 16:00
27.96
-0.02
(-0.07%)
After-Hours: 20:00
Pfizer Total Assets (Quarterly) : 201.13B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 201.13B |
| March 31, 2026 | 207.62B |
| December 31, 2025 | 208.16B |
| September 30, 2025 | 208.73B |
| June 30, 2025 | 206.10B |
| March 31, 2025 | 208.03B |
| December 31, 2024 | 213.40B |
| September 30, 2024 | 219.48B |
| June 30, 2024 | 216.19B |
| March 31, 2024 | 221.10B |
| December 31, 2023 | 226.50B |
| September 30, 2023 | 215.02B |
| June 30, 2023 | 220.17B |
| March 31, 2023 | 195.62B |
| December 31, 2022 | 197.20B |
| September 30, 2022 | 195.35B |
| June 30, 2022 | 195.29B |
| March 31, 2022 | 183.84B |
| December 31, 2021 | 181.48B |
| September 30, 2021 | 179.19B |
| June 30, 2021 | 169.92B |
| March 31, 2021 | 158.82B |
| December 31, 2020 | 154.23B |
| September 30, 2020 | 178.98B |
| June 30, 2020 | 177.93B |
| Date | Value |
|---|---|
| March 31, 2020 | 166.34B |
| December 31, 2019 | 167.49B |
| September 30, 2019 | 170.45B |
| June 30, 2019 | 156.20B |
| March 31, 2019 | 155.42B |
| December 31, 2018 | 159.42B |
| September 30, 2018 | 167.84B |
| June 30, 2018 | 164.98B |
| March 31, 2018 | 164.61B |
| December 31, 2017 | 171.80B |
| September 30, 2017 | 172.15B |
| June 30, 2017 | 168.56B |
| March 31, 2017 | 168.78B |
| December 31, 2016 | 171.62B |
| September 30, 2016 | 178.43B |
| June 30, 2016 | 170.66B |
| March 31, 2016 | 162.93B |
| December 31, 2015 | 167.46B |
| September 30, 2015 | 170.87B |
| June 30, 2015 | 160.88B |
| March 31, 2015 | 160.64B |
| December 31, 2014 | 169.27B |
| September 30, 2014 | 171.36B |
| June 30, 2014 | 172.61B |
| March 31, 2014 | 171.81B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| Merck & Co., Inc. | 129.80B |
| Bristol Myers Squibb Co. | 87.63B |
| Viatris, Inc. | 35.04B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 115.64B |
| Shareholders Equity (Quarterly) | 85.19B |
| Debt to Equity Ratio | 0.7418 |
| Current Ratio | 1.267 |
| Net Debt Paydown Yield | -0.16% |